Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-04-22, Stock:JNJ, The news for the past five days is as follows:
2021-04-15: NEWS1: ‘What determines when?’ Dr. Fauci outlines when COVID-19 will no longer be a ‘threat’.NEWS2: Mass vaccination was never expected to go perfectly — or provide 100% protection against COVID-19.NEWS3: Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?.NEWS4: How J&J's Coronavirus Vaccine Fiasco Could Benefit Novavax And Others.NEWS5: Coronavirus update: J&J vaccine pause remains, Oxford studies blood clots and COVID-19 vaccines.NEWS6: More domestic medical supply manufacturing is ‘critical’ for the U.S. : Premier President.NEWS7: FDA, CDC precaution with vaccine side effects is ‘encouraging’: Doctor.NEWS8: Getting COVID creates far higher risk of rare blood clots than vaccines, Oxford study finds.NEWS9: When COVID hit home for NYC’s health commissioner Dr. Dave Chokshi.NEWS10: Global tally of COVID-19 cases tops 138 million as CDC committee opts to extend pause on J&J vaccine.NEWS11: Vaccination in the U.S. was never expected to go perfectly — or provide 100% protection against COVID-19.NEWS12: Dow ETF at All-Time Highs as Q1 Earnings Kick Off.NEWS13: J&J Vaccine Pause Could Boost Pfizer, Moderna Stock.NEWS14: Moderna (MRNA) Gives Pipeline Update, to Initiate New Pivotal Study.NEWS15: Poland starts J&J COVID-19 jabs, says benefits outweigh risks.NEWS16: UK scientists find higher risk of brain clots from COVID-19 compared with vaccines.NEWS17: SMART Global, General Motors, Moderna, BioNTech and Johnson & Johnson highlighted as Zacks Bull and Bear of the Day.NEWS18: Inovio Is Still Working On A Midstage Covid Vaccine Test — Is It A Buy?.NEWS19: Will J&J (JNJ) Kickstart Pharma Q1 Earnings With a Beat?.NEWS20: UPDATE 1-Hungary in talks to plug expected shortfall in COVID-19 vaccine deliveries.NEWS21: Coronavirus tally: Global cases of COVID-19 top138 million and UI.S. death toll above 564,000.NEWS22: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.NEWS23: India vows to decide on foreign vaccines within 3 days to fast-track imports.NEWS24: Johnson & Johnson and AstraZeneca sagas illustrate strength of COVID-19 strategy: ‘It was a wise decision to spread the risk’.NEWS25: What Johnson & Johnson and AstraZeneca’s problems reveal about the COVID-19 mass-vaccination campaign.NEWS26: Norway delays AstraZeneca vaccine ruling to further probe risks.
2021-04-16: NEWS1: UPDATE 1-J&J scientists refute idea that COVID-19 vaccine's design linked to clots.NEWS2: Stock Market Rally Keeps Rising As Treasury Yields Fall Despite Strong Earnings, Economic Data; Goldman, Nvidia, Coinbase In Focus.NEWS3: 'You can think of it like an annual flu shot': Doctor on possible COVID-19 booster shots.NEWS4: Why comparing blood clot risks from COVID-19 vaccines and birth control pills doesn’t work.NEWS5: The push to vaccinate farm workers against COVID-19.NEWS6: J&J scientists refute 'class effect' to blame for clots in those who got its COVID-19 vaccine.NEWS7: Vaccinating kids will be very important in getting to herd immunity: Expert.NEWS8: Here’s how the ‘pause’ on J&J’s COVID-19 shot may or may not affect the company’s earnings.NEWS9: Drug companies to face first opioid trial following pandemic delays.NEWS10: Doctor: COVID-19 vaccines 'do lead to a really strong immune response'.NEWS11: J&J’s Vaccine Pause Could Have Ripple Effects for the World.NEWS12: The expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%.NEWS13: UPDATE 2-J&J COVID-19 vaccine pause to be reviewed by U.S. panel next week.NEWS14: WHO says global COVID-19 cases nearly doubled in last two months, making vaccine drive more urgent than ever.NEWS15: CDC committee to meet again on April 23 to discuss J&J's COVID-19 shot.NEWS16: Moderna, Pfizer Rebuffed J&J Proposal for Joint Vaccine Safety Exam, WSJ Reports.NEWS17: Merck (MRK) Stops MK-7110 Development, Focuses on Molnupiravir.NEWS18: The J&J Vaccine Pause Should Worry Us All. What to Know..NEWS19: Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline.NEWS20: This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar.NEWS21: UPDATE 1-Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks - WSJ.NEWS22: Norway delays decision to ditch AstraZeneca vaccine, warning it could impact J&J rollout.NEWS23: Will Solid Pharma Unit Performance Drive J&J (JNJ) Q1 Earnings?.NEWS24: Pfizer, Moderna Reportedly Decline J&J Request to Study Clot Risk.
2021-04-19: NEWS1: Philippines approves emergency use of J&J, Bharat BiotechCOVID-19 vaccines.NEWS2: Emergent Factory Halt Adds to Obstacles for J&J’s Covid Vaccine.NEWS3: UPDATE 5-J&J, other drugmakers go to trial in California in $50 bln case over 'deadly legacy' of opioids.NEWS4: Gold prices end lower after biggest weekly rise since December.NEWS5: What does a strong reaction to a COVID-19 vaccine mean?.NEWS6: Doctor on J&J vaccine: ‘You have a much higher risk of getting a blood clot if you smoke’.NEWS7: Emergent BioSolutions Stock Falls After FDA Initiates Inspection Of Bayview Facility.NEWS8: UPDATE 2-J&J COVID-19 vaccine reviewed for links to additional reports of severe side effects -CDC.NEWS9: Why Emergent BioSolutions Stock Is Tumbling Today.NEWS10: 2 Things Investors Need to Look For in Johnson & Johnson's Earnings Tomorrow.NEWS11: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS12: Doctor on J&J vaccine: It comes down to 'the benefit-risk ratio'.NEWS13: U.S. agency reviewing potential additional cases of severe side effects linked to J&J shot - CDC.NEWS14: South Africa's vaccine compensation fund could cost $17.5 mln in first year.NEWS15: Gold prices pull back after biggest weekly rise since December.NEWS16: U.S. COVID-19 vaccine program meets key goal, but India cases and Brazil deaths worry experts.NEWS17: U.S. hits vaccine milestone despite rise in COVID cases.NEWS18: Johnson & Johnson Reports Earnings Tuesday. Here’s What to Expect..NEWS19: ‘The more we talk about it, the more we’re validating the symptoms’: What we know about COVID vaccine side effects in women.NEWS20: What Does J&J's Pause Mean for Investors?.NEWS21: J&J, other drugmakers go to trial in California in $50 billion case over 'deadly legacy' of opioids.NEWS22: Gold prices slip Monday after biggest weekly rise since December.NEWS23: Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings?.NEWS24: What to Know About Bitcoin’s Terrible Weekend—and Dogecoin’s Wicked Rally.NEWS25: How to Trade Johnson & Johnson After It Reports Earnings.NEWS26: UPDATE 3-California counties at trial argue J&J, other drugmakers fueled opioid epidemic.NEWS27: JNJ COVID-19 Vaccine Could Return This Week With Warning, Says Anthony Fauci.NEWS28: 5 Blue-Chip Stocks Likely to Gain on Q1 Earnings This Week.NEWS29: UPDATE 4-J&J COVID-19 vaccine manufacturing halted at U.S. plant that had contamination issue.NEWS30: Emergent BioSolutions says it has agreed with FDA not to manufacture new material at Baltimore facility.NEWS31: J&J, other drugmakers to face trial in California over claims they fueled opioid epidemic.NEWS32: Johnson & Johnson Slips on Vaccine Commitment As FDA Moves on EBS.NEWS33: Johnson & Johnson Gains on Vaccine Commitment As FDA Moves on EBS.NEWS34: What determines when Americans reclaim their ‘liberty’? Here is Dr. Fauci’s answer.NEWS35: The public’s expectation of perfection: Risk of blood clot from Johnson & Johnson COVID-19 vaccine is 0.00009%.NEWS36: Here’s what we know about COVID-19 vaccine side effects in women.NEWS37: J&J/Alex Gorsky: pay wrongly downplays negatives.
2021-04-20: NEWS1: Johnson & Johnson Rises on 1st-Quarter Earnings Beat.NEWS2: Covid-19 vaccines aren’t making any money for Johnson & Johnson.NEWS3: Key Decisions Coming on Products From Vertex, AstraZeneca and Other Pharmas.NEWS4: Dow Slides As Procter & Gamble Move Raises Inflation Fears; JNJ Rallies On Vaccine News.NEWS5: Bellwether J&J Squashes First-Quarter Views; Will Other Medical Stocks Follow?.NEWS6: Fauci: JNJ vaccine may return Friday with new limits.NEWS7: UPDATE 2-J&J to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says.NEWS8: EU regulatory agency links J&J COVID-19 vaccine to rare blood clots.NEWS9: Dow Jones Loses 300 Points; These Blue Chips Score Breakouts On Earnings.NEWS10: Dow Jones Slumps 300 Points, But IBM Flashes Buy Signal; Apple Debuts New iMacs, iPad Pro Tablets.NEWS11: Johnson & Johnson vaccine ‘pause’ isn’t crimping confidence in the vaccination process, survey says.NEWS12: Pandemic eviction bans found to protect entire communities from COVID-19: Study.NEWS13: Dow Jones Slumps 250 Points, But IBM Flashes Buy Signal; Leading Growth Stocks, Small Caps Crushed Again.NEWS14: Netherlands to resume use of J&J COVID-19 vaccine, says health minister.NEWS15: German scientist: J&J to cooperate in study of rare clots linked to COVID-19 vaccine.NEWS16: J&J to resume COVID-19 vaccine shipments to EU, with a warning 'very rare' adverse events.NEWS17: EMA Finds Potential Blood Clot Link With JNJ COVID-19 Shot, Adds Safety Warning.NEWS18: Dow Jones Dives 300 Points Despite IBM, J&J Gains As Stock Market Gets Slammed.NEWS19: Dow Jones Sells Off As Apple Slides Ahead Of 'Spring Loaded' Event; Tesla Jumps On Price Target Boost.NEWS20: Johnson & Johnson (JNJ) Q1 2021 Earnings Call Transcript.NEWS21: Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) Review.NEWS22: J&J Signals Optimism With Covid Vaccine Use in Limbo in U.S..NEWS23: European Health Regulators Add Blood Clot Warning to J&J’S Covid-19 Vaccine.NEWS24: Global tally of COVID-19 cases top 142 million as India’s surge raises the alarm.NEWS25: Dow Jones Falls As Apple Reverses Ahead Of 'Spring Loaded' Event; Tesla Jumps On Price Target Boost.NEWS26: Vaccine Stocks Checkup: Johnson & Johnson Is Rising.NEWS27: Better-than-Expected Corporate Earnings.NEWS28: COVID vaccine 'on track' after blood clot scare: Johnson & Johnson CFO.NEWS29: US STOCKS-S&P 500, Dow slip as focus turns to tech earnings.NEWS30: P&G, J&J Beat on Earnings, Drop in Pre-Market.NEWS31: Johnson & Johnson vaccine should get blood-clot warning, European agency says.NEWS32: UPDATE 5-EU regulator backs J&J shot, finds possible link to clots.NEWS33: Emergent (EBS) Bayview Unit Operation on Hold for FDA Probe.NEWS34: J&J (JNJ) Q1 Earnings Top, COVID-19 Vaccine Brings $100M Sales.NEWS35: How Johnson & Johnson Beat Expectations in Q1.NEWS36: Johnson & Johnson CFO: COVID vaccine 'on track' after blood clot scare.NEWS37: J&J to resume rollout of COVID-19 vaccine in Europe with safety warning.NEWS38: Johnson & Johnson Just Reported Earnings. This Number Is Critical..NEWS39: The Zacks Analyst Blog Highlights: Johnson & Johnson, Verizon, Dow, American Express and Honeywell.NEWS40: Warren Buffett Owns These 5 Dividend Aristocrats. Should You?.NEWS41: 5 Top Stock Gainers Tuesday: Kansas City Southern, IBM, Fisker.NEWS42: Johnson & Johnson (JNJ) Beats Q1 Earnings and Revenue Estimates.NEWS43: Pfizer (PFE)/ BioNTech to Supply Extra Comirnaty Doses to EU.NEWS44: Johnson & Johnson Beat Q1 Earnings, Boosts 2021 Guidance; Reports $100M In COVID-19 Vaccine Sales.NEWS45: Johnson & Johnson Earnings Top, Dividend Hiked.NEWS46: UPDATE 1-J&J seeks approval to conduct local trial of its COVID-19 vaccine in India.NEWS47: J&J beats profit and sales expectations, boosts dividend; COVID-19 vaccine adds $100 million to sales.NEWS48: UPDATE 4-J&J stands ready to roll out COVID-19 vaccine in Europe.NEWS49: J&J reports $100 million in vaccine sales as results top forecasts.NEWS50: Johnson & Johnson to Host Earnings Call.NEWS51: Johnson & Johnson Reports 2021 First-Quarter Results:.NEWS52: Johnson & Johnson Announces Dividend Increase of 5.0%.NEWS53: 3 Dividend Aristocrats to Buy and Hold Forever.NEWS54: Johnson & Johnson Tops Earnings Forecast, Boosts Guidance: Shares Gain.NEWS55: Johnson & Johnson Earnings Preview: Here’s What You Need To Know.NEWS56: Covid vaccines and the race to understand blood clots.NEWS57: Johnson & Johnson sells $100m of coronavirus vaccines in first quarter.
2021-04-21: NEWS1: Stock Market News About Johnson & Johnson, NVIDIA, and More.NEWS2: Pfizer identifies fake COVID-19 shots abroad.NEWS3: Spain likely to start J&J COVID vaccinations on Thursday, minister says.NEWS4: I’m confident in the J&J vaccine and its effectiveness: NewYork Presbyterian CEO.NEWS5: UPDATE 1-South African researchers hope to resume J&J vaccination study next week.NEWS6: UPDATE 1-Greece to start J&J coronavirus vaccinations on May 5.NEWS7: EXPLAINER-How worried should we be about blood clots linked to Astra, J&J vaccines?.NEWS8: EU says J&J vaccine benefits outweigh risks, Pfizer finds fake COVID-19 shots .NEWS9: Healthcare ETFs in Focus Post JNJ's Q1 Earnings Results.NEWS10: FDA inspection of Emergent's COVID-19 vaccine plant identifies 'potential quality issues'.NEWS11: RPT-UPDATE 1-U.S. FDA finds peeling paint, debris at U.S. plant making J&J's COVID-19 vaccine.NEWS12: 12 Best Value Dividend Stocks to Buy Now According to Warren Buffett.NEWS13: Peeling paint, shoddy cleanups among issues at U.S. plant making J&J COVID-19 vaccine - FDA.NEWS14: J&J (JNJ) Gets Usage Guidance for COVID-19 Vaccine in Europe.NEWS15: UPDATE 6-Peeling paint, shoddy cleanups among issues at U.S. plant making J&J COVID-19 vaccine -FDA.NEWS16: Company News for Apr 21, 2021.NEWS17: EU snubs extra 300 mln J&J, Astra shots in bet on Pfizer-source.NEWS18: J&J resumes European COVID-19 vaccine rollout with regulator-mandated safety warning.NEWS19: Dow Jones Futures: Netflix Dives On Subscriber Miss, Chip Giant ASML Rallies After Market Retreat Slams Leaders.NEWS20: House Democrats Investigating Emergent BioSolutions' Vaccine Contracts, Call On Execs To Testify.NEWS21: Is Pfizer Stock A Buy As The Company Bolsters Its Covid Vaccine Supply?.NEWS22: Is J&J Stock A Sell As Blood-Clot Questions Plague Its Covid Vaccine?.NEWS23: Is AstraZeneca a Bad-News Buy?.NEWS24: Dow Jones Futures: Market Retreat Slams Leaders; Netflix Dives On Subscriber Miss, But This Top Tech Rallies.NEWS25: UPDATE 2-EU countries ready to start using J&J shot as deliveries resume.NEWS26: 2 Reasons This COVID Vaccine Latecomer Could Gain Major Market Share.NEWS27: Bear of the Day: OrganiGram Holdings (OGI).NEWS28: Why Novavax Could Be the Biggest Winner From Johnson & Johnson's Vaccine Woes.NEWS29: Will Blood Clot Issues Make Johnson & Johnson's COVID Vaccine a Loser?.

Answer: Decrease